Biological E seeks DCGI’s nod for phase-III trial of Corbevax as booster dose in those vaccinated with Covishield or Covaxin Read more
Covishield single-dose efficacy drops after 16 weeks in people above 60 years: Sri Lankan research Read more
Covishield gives 93 per cent protection against COVID and 98 per cent mortality reduction: AFMC Read more
Only marginal difference in purchase price of Covishield and Covaxin for Centre: MoS Health Read more